4.7 Review

Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future

期刊

出版社

MDPI
DOI: 10.3390/ijms24087176

关键词

intestinal microbiota; microRNA; dysbiosis; ulcerative colitis; Crohn's disease; inflammatory bowel

向作者/读者索取更多资源

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder characterized by an overactive immune response to environmental factors, including gut microbiota and dietary components. MicroRNAs (miRNAs) have been associated with various physiological processes and play a role in the regulation of inflammatory pathways. Differences in miRNA profiles can be used as a diagnostic and prognostic marker in IBD. The interaction between miRNAs and intestinal microbiota is still not fully understood, but recent studies have shown their role in modulating intestinal homeostasis.
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC) and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and dysregulated immune responses to environmental factors, including gut microbiota and dietary components. An imbalance of the intestinal microbiota may contribute to the development and/or worsening of the inflammatory process. MicroRNAs (miRNAs) have been associated with various physiological processes, such as cell development and proliferation, apoptosis, and cancer. In addition, they play an important role in inflammatory processes, acting in the regulation of pro- and anti-inflammatory pathways. Differences in the profiles of miRNAs may represent a useful tool in the diagnosis of UC and CD and as a prognostic marker in both diseases. The relationship between miRNAs and the intestinal microbiota is not completely elucidated, but recently this topic has gained prominence and has become the target of several studies that demonstrate the role of miRNAs in the modulation of the intestinal microbiota and induction of dysbiosis; the microbiota, in turn, can regulate the expression of miRNAs and, consequently, alter the intestinal homeostasis. Therefore, this review aims to describe the interaction between the intestinal microbiota and miRNAs in IBD, recent discoveries, and perspectives for the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据